Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Med Arch ; 70(1): 44-7, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26980931

RESUMEN

AIM: The aim of this study was to evaluate biochemical parameters in serum of women with preeclampsia and IUGR. MATERIAL AND METHODS: A clinical prospective study was conducted and included 120 pregnant women divided in two groups: non IUGR group included healthy pregnant women (n=60) and IUGR group included pregnant women with preeclampsia and IUGR (n=60). Outcome measures were following values of biochemical parameters in serum of mother and fetuses: aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), bilirubin (indirect and direct) and cholesterol. A blood for analysis was drawn from the cubital vein of mothers and the umbilical vein of the fetuses during delivery period. RESULTS: The mean of maternal age was 30.0±6.1 years in women with preeclampsia and IUGR and 28.1±5.1 years in healthy pregnant women, p > 0.05. The most of women with preeclampsia and IUGR had grade III of placental maturation (48.3%). There is a significant association between the placental maturation and the diagnosis, p < 0.001. There was a statistically significant difference in body mass of newborns between IUGR and non IUGR groups, p < 0.001. There was a significant statistically difference in serum value of AST, ALT, LDH and total cholesterol between women with preeclampsia and IUGR and healthy pregnant women (all p < 0.001). CONCLUSION: Measurement of AST, ALT, LDH, and total cholesterol in serum of pregnant women and newborns with IUGR allows the differentiation and threatening risk of perinatal complications due to hypoxia.


Asunto(s)
Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Retardo del Crecimiento Fetal/sangre , Retardo del Crecimiento Fetal/diagnóstico , L-Lactato Deshidrogenasa/sangre , Preeclampsia/sangre , Preeclampsia/diagnóstico , Adulto , Bilirrubina/sangre , Biomarcadores/sangre , Peso al Nacer , Índice de Masa Corporal , Colesterol/sangre , Femenino , Humanos , Recién Nacido , Valor Predictivo de las Pruebas , Embarazo , Pronóstico , Estudios Prospectivos , Sensibilidad y Especificidad
2.
Med Arch ; 67(6): 431-4, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25568515

RESUMEN

INTRODUCTION: Postmenopausal uterine bleeding is a "cancer until proven otherwise". Endometrial cancer is a typical disease among postmenopause woman, because every bleeding in this age etiology associated with endometrial cancer (10-30%). The lifespan of women today has been extended and post menopause today last one third of a woman's life. Early diagnosis of endometrial cancer has a very high cure rate. Screening for this cancer has limits in practice and is necessary given the definition of high-risk groups would be subject to primary and secondary prevention. GOAL: Primary to evaluate the leading causes of postmenopausal uterine bleeding among patients at risk for endometrial cancer (diabetes, obesity, nulliparity, late menopause (after 55 years) and compared them with the causes of postmenopausal uterine bleeding patients without this risk. MATERIAL AND METHODS: A retrospective, descriptive study with a targeted sample of 50 consecutive patients who had registered postmenopausal uterine bleeding in high-risk groups (cohorts) and the same number of patients with postmenopausal uterine bleeding that does not belong to the risk group (control group). Each patient underwent clinical examination, then fractionated curettements and its histopathological verification and assessment of treated clinical stage of disease with PH analysis of the resected specimens. RESULTS: The patients of the studied risk group were significantly affected by endometrial cancer compared with the control group (RR=2.45, 95% CI 1.2 4.6, p=0.005). Endocervical pathology did not differ between groups. Clinical forms of bleeding: for those that are profuse bleeding cancer was present in 54.6% of cases. With intermittent bleeding cancer is verified in the 33.3% of patients. Risk patient groups with cancer frequently suffer from clinically more advanced stages of histologically aggressive endometrial cancer (serous adenocarcinoma-type II, low differentiated cancer).


Asunto(s)
Detección Precoz del Cáncer , Neoplasias Endometriales/diagnóstico , Endometrio/patología , Posmenopausia/fisiología , Hemorragia Uterina/patología , Neoplasias Uterinas/diagnóstico , Anciano , Femenino , Humanos , Persona de Mediana Edad , Tamaño de los Órganos , Estudios Retrospectivos , Factores de Riesgo , Ultrasonografía , Hemorragia Uterina/etiología
3.
Acta Inform Med ; 24(1): 12-5, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27046941

RESUMEN

AIM: The aims of this study were to compare ultrasound fetoplacental parameters and to calculate Hepato-Cephalic Index (HCI) as a new predictor of IUGR. METHODS AND MATERIAL: A clinical prospective study was conducted and included 120 pregnant women divided in two groups: non IUGR group included healthy pregnant women (n=60) and IUGR group included pregnant women with preeclampsia and IUGR (n=60). Outcome measures were following ultrasound fetoplacental parameters in fetuses with IUGR and non IUGR: Fetal Liver Length (FLL), Femur Length (FL), Biparietal Diameter (BPD), Placental Maturation by Grannum, Amniotic Fluid Index (AFI) and Hepato-Cephalic Index (HCI). Sonography was carried out by probe 3.5 Mhz type MINDRAY DC 7. RESULTS: The mean of maternal age was 30.0±6.1 years in women with preeclampsia and IUGR and 28.1±5.1 years in healthy pregnant women, p > 0.05. There was a statistically significant difference in values of: FLL (p < 0.001), FL (p = 0.004), BPD (p < 0.001), AFI (p < 0.001), HCI (p < 0.001) between IUGR and non IUGR groups. The most of women with preeclampsia and IUGR had grade III of placental maturation (48.3%). There is a significant association between the placental maturation and the diagnosis, p < 0.001. There was a statistically significant difference in body mass of newborns between IUGR and non IUGR groups, p < 0.001. CONCLUSION: In a fetus with IUGR in preeclampsia there is a reduction in FLL, FL, BPD, AFI and HCI and there is a early maturation of the placenta. By measurement of fetoplacental ultrasonic parameters of liver, pregnant women will experience prediction of risk pregnancy (preeclampsia with IUGR) due to hypoxia.

4.
Med Arh ; 58(2): 121-3, 2004.
Artículo en Bs | MEDLINE | ID: mdl-15202322

RESUMEN

Elective repeat cesarean section continues to remain the standard to care at GYK and OBST. Department in Sarajevo. This paper is a study of 216 patients with previous cesarean section who requested and were allowed a trial of labor. One hundred fifty-six (72%) achieved successful vaginal delivery with no maternal or fetal mortality or significant morbidity. Review of the USA literature indicates similar results in other independent studies. Continued accumulation of cases showing the efficacy of post-cesarean section trial of labor should encourage a reassessment of the continuing practice of elective repeat cesarean section.


Asunto(s)
Cesárea , Esfuerzo de Parto , Adulto , Peso al Nacer , Cesárea Repetida , Femenino , Humanos , Recién Nacido , Embarazo , Parto Vaginal Después de Cesárea/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA